VaccineNation Interview with Ricarda Finnern - WVC EU 2024

At the World Vaccine Congress in Barcelona, we had the pleasure of sitting down with Dr. Ricarda Finnern, Chief Scientific Officer at LenioBio. She shared exciting insights into their groundbreaking cell-free protein production technology, which is transforming the landscape of vaccine development and beyond.

Highlights from the conversation:
1️⃣ Overcoming Bottlenecks: LenioBio’s technology produces proteins in a cell-free environment, eliminating time-consuming cell-line development and enabling faster responses to emerging pathogens.
2️⃣ The ALiCE Platform: With the ability to scale from research to clinical production, the platform can produce proteins in just 24–48 hours, enhancing agility for pandemic preparedness and other critical applications.
3️⃣ Building Ecosystems: Dr. Finnern emphasized the importance of collaboration, calling for a unified approach to leverage innovative technologies across industries.

🎯 Why it matters:
By removing traditional barriers, LenioBio is not just accelerating vaccine production but is also contributing to a flexible, scalable, and sustainable manufacturing paradigm.

🎟️Register now! https://www.terrapinn.com/WVCEU/Tickets

📆 Pre-Congress Workshops | 13 October 2025
📆 Main Congress | 14-16 October 2025
📍RAI Convention Centre, Amsterdam, Netherlands

#WVCEU #WorldVaccineCongress #Vaccine #HealthcareInnovation
#HealthcareLeaders

Visit our Website: http://www.terrapinn.com/2013/world-v...
Read our blog: http://blogs.terrapinn.com/vaccinenat...
Follow us on Twitter: @vaccinenation
Join our Linkedin group:   / vaccine-nation-1351197